Rchr
J-GLOBAL ID:200901016079944744
Update date: Mar. 11, 2024
Kinoshita Ichiro
キノシタ イチロウ | Kinoshita Ichiro
Affiliation and department:
Job title:
Professor
Other affiliations (2):
Research field (1):
Respiratory medicine
Research keywords (2):
腫瘍内科学
, 呼吸器内科学
Research theme for competitive and other funds (15):
- 2022 - 2025 A Study on Predicting the Effectiveness of Cancer Immunotherapy
- 2021 - 2024 小細胞肺癌におけるProx1によるNotch pathwayの制御機構、治療開発
- 2020 - 2023 Optimization of treatment strategy with EZH2 inhibitor for solid cancer with SWI/SNF alteration
- 2018 - 2021 Numb has distinct roles in lung adenocarcinoma and squamous cell carcinomaus us
- 2017 - 2020 Development of potential therapy using histone modifying enzyme inhibitor to overcome drug resistance of non-small lung cancer
- 2014 - 2017 Combined inhibition of stem cell markers and histone modification enzymes in non-small cell lung cancer
- 2014 - 2016 Study on EGFR-TKI resistance using FRET biosensor
- 2012 - 2015 Combined antitumor effec ot g-secretase inbitiro and ABT-737
- 2011 - 2013 Targeted therapy for cancer stem-like cells of non-small cell lung cancers with inhibition of the cJun transcription factor
- 2010 - 2012 Alteration of fucosylation and biomarker development in lung cancer
- 2008 - 2010 Identification of novel molecular targets for lung cancer based on different sensitivity to AP-1 blockade
- 2006 - 2007 肺癌および随伴肺疾患における糖転移酵素の発現異常に関する研究
- 2004 - 2006 Research on Molecular Therapeutic Targets and Biomarkers for the Diagnosis and Stratification in Lung Cancer
- 2004 - 2005 Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant negative mutant, TAM67
- 肺癌のAP-1を標的にした遺伝子治療に関する基礎的研究 転写因子E1AF/PEA3に関する研究 肺癌のEGFRの異常とGefitinib感受性
Show all
Papers (158):
-
Takuya Watanabe, Yoshitaka Saito, Yoh Takekuma, Yasushi Shimizu, Ichiro Kinoshita, Yoshito Komatsu, Mitsuru Sugawara. Evaluation of the risk factors for the failure of a single prophylactic dose of anticholinergic drugs for irinotecan-induced cholinergic symptoms. International journal of clinical pharmacology and therapeutics. 2024
-
YOSHITAKA SAITO, TATSUHIKO SAKAMOTO, MASAKI KOBAYASHI, YOH TAKEKUMA, ISSEI HIGUCHI, KEISUKE OKAMOTO, JUN SAKAKIBARA-KONISHI, YASUSHI SHIMIZU, ICHIRO KINOSHITA, MITSURU SUGAWARA. Evaluation of Prediabetes in Cisplatin-induced Nephrotoxicity in the Short Hydration Method: A Subgroup Analysis. In Vivo. 2024. 38. 2. 800-806
-
Yoshitaka Saito, Shinya Tamaki, Daisuke Hirate, Shinya Takada, Kenta Takahashi, Yoh Takekuma, Jun Sakakibara-Konishi, Yasushi Shimizu, Ichiro Kinoshita, Mitsuru Sugawara. Detection of factors related to treatment reduction in docetaxel and ramucirumab for non-small cell lung cancer treatment. Scientific reports. 2023. 13. 1. 19457-19457
-
Yoshitaka Saito, Masaki Kobayashi, Shinya Tamaki, Katsuyuki Nakamura, Daisuke Hirate, Kenta Takahashi, Yoh Takekuma, Jun Sakakibara-Konishi, Yasushi Shimizu, Ichiro Kinoshita, et al. Risk factor analysis for cisplatin-induced nephrotoxicity with the short hydration method in diabetic patients. Scientific reports. 2023. 13. 1. 17126-17126
-
Satoshi Takeuchi, Kenji Hirata, Keiichi Magota, Shiro Watanabe, Rika Moku, Akihiko Shiiya, Jun Taguchi, Shin Ariga, Tomohiro Goda, Yoshihito Ohhara, et al. Early prediction of treatment outcome for lenvatinib using 18F-FDG PET/CT in patients with unresectable or advanced thyroid carcinoma refractory to radioiodine treatment: a prospective, multicentre, non-randomised study. EJNMMI research. 2023. 13. 1. 69-69
more...
MISC (200):
-
菊地 順子, 菊地 英毅, 木下 一郎. 肺がん-Lung cancer-特集 先端ゲノム医療とゲノム診療 ; 各臓器がんのゲノム診療の現状. 腫瘍内科 = Clinical oncology / 腫瘍内科編集委員会 編. 2021. 27. 1. 81-86
-
木下 一郎, 加納 里志, 清田 尚臣, 多田 雄一郎, 伊地知 圭, 山崎 知子, 西本 尚樹, 畑中 豊, 松野 吉弘, 秋田 弘俊. HER2陽性再発・転移唾液腺癌患者に対するトラスツズマブ・ドセタキセル併用療法の第II相試験. 日本内科学会雑誌. 2020. 109. Suppl. 230-230
-
庄司 哲明, 菊地 英毅, 菊地 順子, 前田 真希枝, 高島 雄太, 古田 恵, 高橋 宏典, 木下 一郎, 秋田 弘俊, 榊原 純, et al. シスプラチン耐性肺癌の治療標的としての免疫プロテアソームの検討. 肺癌. 2019. 59. 6. 908-908
-
庄司 哲明, 菊地 英毅, 菊地 順子, 高島 雄太, 古田 恵, 木下 一郎, 秋田 弘俊, 榊原 純. シスプラチン耐性肺癌の治療標的としての免疫プロテアソームの検討(Analysis of immunoproteasome as a therapeutic target in cisplatin-resistant small and non-small cell lung cancer). 日本癌学会総会記事. 2019. 78回. P-1001
-
Ichiro Kinoshita, Satoshi Kano, Yasushi Shimizu, Naomi Kiyota, Yuichiro Tada, Kei Ijichi, Tmoko Yamazaki, Akihiro Homma, Yoichi M. Ito, Kota Ono, et al. Phase II study of trastuzumab and docetaxel therapy in patients with HER2-positive recurrent and/or metastatic salivary gland carcinoma. CANCER RESEARCH. 2019. 79. 13
more...
Books (1):
Works (1):
-
スライドセミナー内科系:日本臨床細胞学会北海道支部会
2009 -
Education (2):
- - 1988 Hokkaido University School of Medicine
- - 1988 Hokkaido University Faculty of Medicine
Professional career (1):
- MD, PhD (Hokkaido University)
Work history (9):
- 2021/06 - 現在 Hokkaido University Hokkaido University Hospital
- 2019/07 - 現在 Hokkaido University Hospital Division of Clinical Cancer Genomics Professor
- 2012/09 - 2019/06 Hokkaido University Department of Medical Oncology, Graduate School of Medicine Associate Professor
- 2005 - - 北海道大学講師(大学院医学研究科腫瘍内科学分野) 講師
- 2005 - - Lecturer
- 2004 - - 北海道大学助手(大学院医学研究科腫瘍内科学分野) 助手
- 2004 - - Research Associate
- 2001 - - 北海道大学助手(医学部附属病院内科学第一講座) 助手
- 2001 - - Research Associate
Show all
Committee career (8):
Awards (1):
Association Membership(s) (16):
American Society of Clinical Oncology
, 世界肺癌学会
, 日本乳癌学会
, 日本分子標的治療学会
, 日本臨床腫瘍学会
, 日本臨床細胞学会
, 日本呼吸器学会
, 日本気管支学会
, 日本癌治療学会
, 日本癌学会
, アメリカ癌学会
, 北海道癌談話会
, 北海道癌治療研究会
, 日本肺癌学会
, アジア太平洋呼吸器学会
, 日本内科学会
Return to Previous Page